Overheated generic battle

With many global makers' blockbuster products losing patent, the race for the generic drug market is seen to be further intensifying.

According to data by Yakup.com, a pharmaceutical information provider, the industry's top players, including Dong A, Hanmi, Yuhan and Green Cross, may see a steep hike in sales on the back of their latest generic releases.

Generic versions of the four origi...